Are drug prices really too high, as President Trump implies? Robert Zirkelbach, Executive Vice President of Public Affairs for Pharmaceutical Research and Manufacturers of America (PhRMA), and Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), join host John Barkett to discuss whether the prices we pay for prescription drugs represent the value those drugs provide and what could be done to possibly lower prescription drug prices on The Business of Health Care.
Hosted on Acast. See acast.com/privacy for more information.
